Hannah Baker - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Hannah Baker's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Hannah Baker

Hannah Baker

Verified

Medical Writer, reparerx.com

Austin

Final Covers

Women’s Health , Healthcare , Social And Health Inequality

Doesn’t Cover

Seniority Positions

Industries

Medium Formats

Content

Total articles 209

  • TATSU-YA TAQUERO TAKEOVER at Suerte

    By Caitlin Cano, Sarah Connell, Hannah Baker Verified

    Aug. 02, 2022

  • Late Night Glow Show w/ Joey Z at The Ballroom at Spiderhouse

    By Caitlin Cano, Hannah Baker Verified

    Jul. 26, 2022

  • TATSU-YA TAQUERO TAKEOVER at Suerte

    By Caitlin Cano, Sarah Connell, Hannah Baker Verified

    Aug. 02, 2022

As seen in

Company Info

reparerx.com

Repare Therapeutics is a clinical-stage precision oncology company based in Quebec, Canada, founded in 2016. The company focuses on discovering and developing novel therapeutics through a proprietary synthetic lethality approach, targeting genomic instability and DNA damage repair. Utilizing its CRISPR-enabled SNIPRx® platform, Repare Therapeutics systematically identifies and validates targets for cancer therapies. The company has a diverse product pipeline aimed at addressing cancers with significant unmet medical needs and is actively engaged in clinical trials for these candidates. Repare Therapeutics is also involved in strategic partnerships, including the out-licensing of its discovery platforms to DCx Biotherapeutics. Listed on the Nasdaq under the ticker symbol RPTX, Repare Therapeutics operates with a team of 51 to 200 employees and has additional operations in Switzerland. The company is committed to advancing cancer treatment through innovative research and development.

, ,

'+1 857-412-7018

Founded: 2016